Abstract
Neutral comet assay has been available for two decades to evaluate sperm double-strand breaks (DSBs). However, its clinical usability is limited due to its complex and time-consuming procedure, as well as the lack of a standardized scoring system. The aim of this study was to: develop a rapid diagnostic method for DSBs, Sperm DNA Fragmentation Releasing Assay (SDFR), and explore the association between DSBs and reproductive outcomes. We pioneered the use of polyacrylamide (PA) for embedding sperm chromatin and optimized the porosity of PA to be between 10 and 13%. The refined PA network allowed the trapping of DSBs, which dispersed halo on an immunological slide; in contrast, intact chromatin failed to develop a halo. A strong correlation was showed between reproducible values obtained from SDFR and neutral comet assay. SDFR were responsive to dose-/time-dependent simulated DSBs, indicating high sensitivity and specificity. Furthermore, we conducted a retrospective study of couples with embryonic aneuploidy screening, and recording DSB profiles of the male partners. Our findings revealed that DSB enabled to predict embryonic aneuploidy whereas basic semen parameters did not. In conclusion, SDFR offers a rapid and user-friendly approach for evaluating DSBs, with potential implications for predictive healthcare in reproductive medicine.
Similar content being viewed by others
Introduction
Approximately 48.5 million couples suffer from infertility worldwide, with male factors accounting for about 20–30% of all infertility cases1. Basic semen examination covers parameters such as semen volume, sperm concentration, motility, and morphology3. However, up to 40% of male-infertility cases display no identified abnormalities in basic semen parameters4. A meta-analysis on the probability and indication of sperm DNA defects showed that sperm DNA fragmentation (SDF) is a primary diagnostic factor in these idiopathic infertility cases. Moreover, SDF is linked to reproductive failures, including lower fertilization rate5 and clinical pregnancy6.
The WHO 6th edition guideline outlined four standard methods for assessing SDF: (1) TdT (terminal deoxynucleotidyl transferase)-mediated dUTP nick-end labeling (TUNEL), (2) sperm chromatin dispersion (SCD), (3) sperm chromatin structure assay (SCSA), and (4) comet assay5,9. Much attention was given to enhance the reliability of SDF assessment through the integration of fluorescent amplification detection systems6 or high-throughput flow cytometry10. However, the mentioned methods quantify “total” SDF but do not enable the differentiation between single-strand breaks (SSBs) and double-strand breaks (DSBs) in DNA fragments.
Considering DSBs are significantly more lethal than SSBs because they are harder to repair11,12. An early study developed an alternative comet assay by performing the comet assay under neutral conditions13. Neutral comet assay relies on the unique behavior of DSBs under neutral non-denaturing conditions, whereby stretches of DNA molecules between the DSBs physically detach and diffuse from the nucleoid. With the aid of electrophoresis, the detached DSBs migrate to the anode end and form a comet tail. Neutral comet assay has attracted attention due to its ability to exclusively correlate with DSBs in clinical settings. High DSB profile have been pathologically associated with recurrent pregnancy loss14,15, delayed embryo development, and impaired implantation rates16, links that were barely found using conventional methods. However, neutral comet assay has been criticized for being a laborious and time-consuming procedure, with a subjective and unstandardized criterion for DFI quantification, which significantly limits its usability in clinical applications.
In response to the growing need for a time-saving and easy-to-perform method for evaluating DSBs, researchers have explored another molecular property of DSBs. These breaks are preferentially located at matrix attachment regions (MAR regions) of sperm chromatin, where endonucleases actively participate. The endonuclease-dependent DSBs result in specific fragment sizes, typically around 50 kb14,17. The aim of this study was to: (1) develop an innovative technology for DSB evaluation based on their unique molecular characteristics, (2) validate its reliability, sensitivity, and specificity, and (3) use it to explore the clinical association of DSBs with reproductive outcomes.
Materials and methods
Ethics statement
The prospective cohort study was approved by the Institutional Review Board of Chung Shan Medical University and was registered with the reference number CS2-20012. All patients were fully counseled and provided informed written consent before entering the study. The study protocol was designed and validated in accordance with the Declaration of Helsinki.
Participants enrollment
We recruited a total of 640 infertile men who attended Lee Women’s Hospital (Taichung, Taiwan) seeking assisted reproductive treatments from May 2020 to December 2021. Male patients of couples seeking fertility treatment were eligible. The main selection criteria were age 20–60 years old and signed consent for participation in the study. Exclusion criteria in the prospective cohort included patients with azoospermia, and/or retrograde ejaculation.
Basic semen analysis
Semen samples were collected by masturbation into sterile cups following 2–5 days of abstinence. After full liquefaction, aliquots of the semen were loaded into a 10 µm deep chamber slide and analyzed using a CEROS II device (Hamilton-Thorne, Danvers, MA) for sperm concentration, total motility, and progressive motility.
Assessment of total DFI
Total DFI was conducted by LensHooke® R10 Sperm Chromatin Dispersion Assay (Bonraybio, Taichung, Taiwan), according to the manufacturer’s instructions18. Briefly, a tube containing agarose was heated at 100 °C for 5 min and subsequently cooled down at 37 °C. A semen aliquot of 25 μL (10 × 106/mL) and 25 μL denaturant solution were added to the tube, and a 25 μL admixture was placed on a pretreated microscope slide and covered with a 22 × 22 mm coverslip. The slide underwent a lysis reaction at room temperature (RT) for 10 min. The slide was washed with distilled water for 5 min and dehydrated in 95% methanol for 1 min. The slide was stained with Wright-Giemsa solution. A large and/or medium halo were referred to intact sperm DNA and small and/or no halo were fragmented DNA. Total DFI was interpreted under a bright-field microscope (Olympus BX53). At least 500 sperm cells were examined per test.
Assessment of DSB DFI
LensHooke® R11 sperm DNA fragmentation releasing assay
DSB DFI was performed by LensHooke® R11 Sperm DNA Fragmentation Releasing Assay (Bonraybio). A semen aliquot of 70 μL was mixed with 70 μL 30% (w/v) acrylamide/bis-acrylamide solution (BioRad, Hercules, CA), 15 μL 1% (w/v) ammonium persulfate (BioRad), and 15 μL tetramethylethylenediamine (TEMED, BioRad) to initiate gel polymerization in a 1.5 mL microcentrifuge. A 15 μL aliquot of the mixture was immediately placed onto the pretreated microscope slide and covered by a 24 × 40 mm coverslip. The slide was horizontally placed at RT for 5 min and the coverslip was carefully removed. The lysis solution (0.4 M Tris, 1 M Urea, 0.05% SDS, 50 mM TCEP, 50 mM Na2EDTA, 2.5 M NaCl, 1% Triton X-100, and 5 mM NaOH, pH 8.0) was immediately added to the slide and the slide was incubated at RT for 10 min, followed by tilting to drain off the residual reagents. The slide was immersed in distilled water for 5 min, Diff-Quik I for 1 min, Diff Quik II for 1 min, and de-stained with 75% ethanol for 1 min. The dried slide was evaluated under a bright-field microscope. Sperm with a large and/or medium halo were referred to as sperm with DSBs. DSB DFI was calculated as the percentage of spermatozoa with a halo over the total population. A minimum of 500 spermatozoa were scored per test sample.
Neutral comet assay
A semen aliquot of 25 μL (2 × 106/mL) was mixed with 50 μL 1% low melting point agarose. Next, 20 μL sperm–agarose mixture was placed on a Cometslide™ (Trevigen®) for gel adhesion, covered with a coverslip, and solidified at 4 °C for 5 min. The coverslip was gently removed and the slide was incubated with lysis solution 1 (0.8 M Tris–HCl, 0.8 M DTT, 1% SDS, pH 7.5) followed by lysis solution 2 (0.4 M Tris–HCl, 50 mM EDTA, 2 M NaCl, 0.4 M DTT, pH 7.5) for 30 min at RT each. The slide was washed in TBE (0.4 M Tris–HCl, 0.4 M boric acid, 10 mM EDTA) buffer for 10 min. and placed in an electrophoresis tank with freshly prepared TBE buffer. Electrophoresis was performed at 20 V (1 V/cm), 12 mA for 12.5 min. After electrophoresis, the slide was washed with 0.9% NaCl and dehydrated in an ethanol series (70, 90, and 100%) for 2 min each. Finally, the Cometslide was stained with 1 × SYBR™ Green I (Thermo Fisher Scientific Inc) and images were captured using a digital camera imaging system U3CMOS05100kpa and ToupView software (ToupTek Photonics, China), incorporated to an epifluorescence microscope (Olympus BX53). Sperm comet assay images on the captured microphotographs were analyzed using the CometScore 2.0 software (TriTek, Sumerduck, VA). Counting at least 300 sperm cells per sample. Sperm were defined as DSBs following criteria of the length of DNA tail being ≥ 40 µm and having a percentage of the DNA tail over total signal ≥ 20%.
Evaluation of R11 sensitivity and specificity
Time/dose-dependent treatment of DNase I and Alu I
DNase I and Alu I are endonucleases commonly used to simulate DSBs14,19. Accordingly, R11 sample slides were treated with 40 U/mL of deoxyribonuclease I (DNase I) (Zymo Research Corporation, Irvine, CA), prior to the lysis, for 5, 10, 15, and 30 min at 37 °C; alternatively, they were treated with 0, 5, 10, 20, and 40 U/mL DNase I at 37 °C for 30 min to simulate the different degrees of DSBs. Similarly, R11 sample slides were treated with 200 μL 50 U/mL Alu I (New England Biolabs, Ipswich, MA) for 10, 20, 30, and 40 min at 37 °C, while the sample slides were treated with 5, 15, 25, and 50 U/mL Alu I at 37 °C for 30 min. Hereafter, the slides were washed with distilled water and the same procedure as the R11 general protocol, as described above, was followed.
Time/dose-dependent treatment of hydrogen peroxide
Hydrogen peroxide (H2O2) can induce oxidative stress, which predominantly causes SSBs20. The semen samples were incubated with 0.03, 0.15, and 0.3% H2O2 (Sigma Aldrich, St Louis, MO, USA) in PBS at RT for 1 h to generate different SSB levels. After the treatment, semen samples were washed and resuspended in PBS buffer to the proper concentration (10 × 106/mL). The H2O2-pretreated semen aliquots were analyzed by R10 and R11, as described above.
Preimplantation genetic testing for embryonic aneuploidy
In the cohort of this study, 140 couples had two or more embryos undergoing preimplantation genetic testing for aneuploidy (PGT-A) using VeriSeq-NGS at Lee Women’s Hospital. Embryos were classified as aneuploidy if the level of mosaicism was greater than 80% based on the consensus established by international genetic testing community; aneuploidy rates were calculated per number of biopsied blastocysts21.
Statistical analysis
After testing for normal distribution using the Shapiro–Wilk test, the continuous variables with normal distribution were presented as means ± standard deviations (SD), and comparative analysis was performed by using one-way ANOVA. The results with skewed distributions were presented as medians ± interquartile ranges and the Kruskal–Wallis test was applied for pairing analysis. A comparison of DSB DFI measured by R11 and neutral comet assay was performed by Bland–Altman plot analysis. Spearman correlation analysis was used to assess the association between aneuploidy rate and semen parameters. The area under the curve (AUC) was calculated to determine the performance of the prediction model in discriminating aneuploidy from the controls. A p-value less than 0.05 was considered statistically significant. Statistical analysis was performed by Prism software, version 6.01 (GraphPad Software, Inc, San Diego, CA, USA).
Results
Determining the proper concentration of polyacrylamide for DSB detection
The conceptual model of R11 is illustrated in Fig. 1a. By optimizing the polyacrylamide (PA) microgel porosity the DSBs are released and then trapped within the PA network (halo positive). In contrast, due to the feature of the convoluted chromatin structure, the chromatin of the healthy sperm is spatially restricted and fails to disperse to the halo (no halo).
Normozoospermia samples (n = 5) were split into 7 aliquots and each aliquot was embedded into a 7, 10, 13, 16, 19, 22, and 25% PA gel. Quantitative R11 DFI results were no difference between 10 and 25% PA microgels whereas the value significantly increased when using 7% PA (76.9%, p < 0.05) (Fig. 1c). The illustrations of halo were shown in Fig. 1b. In the validation using DNase I treatment, no difference in R11 DFI was observed between 7 and 13% PA groups. However, a significantly lower level of R11 DFI was detected in the 16%, 19%, 22%, and 25% PA groups (p < 0.05) (Fig. 1d). Collectively, 7% PA was too large to trap DSBs, leading to false positive results. Conversely, PA concentration above 13% were too small to disperse the DSBs, resulting in false negative results. Therefore, a PA concentration of 12% was used for further evaluation.
Correlation of DFI between R11 and neutral comet assay
Liquefied semen samples from 15 men were analyzed by R11 and neutral comet assay. There was no significant difference in DSB DFI between the neutral comet (mean ± SD: 10.1 ± 3.1), and R11 assays (mean ± SD: 11.1 ± 3.5) (Fig. 2a). The Bland–Altman plot analysis showed a mean bias of 1.0% and the 95% limit agreement ranged from 6.8% to -4.7%, presenting a good agreement between the two assays (Fig. 2b).
R11 sensitivity and specificity evaluation
By performing time-dependent and dose-dependent enzymatic treatments of DNase I and Alu I, R11 DFI increased alongside the extension of the treatment time and doses (Fig. 3a,b). Conversely, we induced SSBs by H2O2 treatments, and the pretreated specimens were analyzed for the total DFI by R10 and for DSB DFI by R11. Figure 3c shows that the R10 DFI increased dose-dependently with the higher H2O2 concentrations. In contrast, the R11 DFI remained at basal levels regardless of H2O2 concentration. Therefore, R11 can specifically detect sperm DSBs.
Significant correlation of R11 DFI with basic semen parameters
R11 DFI negatively correlated with total motility (Spearman r = -0.2732, p < 0.0001), progressive motility (Spearman r = -0.1236, p = 0.0027), and normal morphology (Spearman r = -0.1870, p < 0.0001). The DFI was positively correlated with the age of the male (Spearman r = 0.3694, p < 0.0001) and R10 DFI (Spearman r = 0.8054, p < 0.0001).
Clinical association of R11 DFI with embryonic aneuploidy
Among five semen parameters: sperm concentration, total motility, normal morphology, R10 (total DFI), and R11 (DSB DFI), R11 (AUC = 0.66, p = 0.0007) possessed value in predicting the prevalence of aneuploidy (high aneuploidy rate ≧ 50%). Given that parental age: female age (AUC = 0.70, p < 0.0001) and male age (AUC = 0.67, p = 0.0002) were also indicated to have clinical relevance with embryonic aneuploidy (Fig. 5a; Supplementary Table S2 online), we performed an adjusted model that excluded advanced female ages (female age > 38-years-old) to account for any confounding factors. The results showed that R11 had the highest value in predicting aneuploidy (AUC = 0.68, p = 0.002) compared to the other semen quality indexes. The R11 threshold was > 8% and the clinical sensitivity and specificity reached the best balance (Fig. 5b; Supplementary Table S3 online).
Discussion
Herein, we demonstrated that LensHooke® R11 rapid assay detects sperm DSBs with high sensitivity and high specificity. R11 opens a new spectrum for male infertility diagnoses due to the identification of distinct sperm DNA damage profiles.
Agarose is commonly used as the materials for sperm chromatin embedding in the conventional methods such as sperm chromatin dispersion (SCD) and comet assays. In the development of R11, we introduced the use of polyacrylamide (PA) for the first time. PA possesses higher molecular complexity than agarose. By optimized porosity at 10–13% PA microgel, we demonstrated that DSBs are effectively trapped within the PA network and the quantitative results are consistent with neutral comet assay (Figs. 1, 2). Attributed to the innovative application of PA and electrophoresis-free procedure, R11 provides a time-saving protocol compared to the neutral comet assay. The average operation of the neutral comet assay is 141.5 min, while it is only 35 min for R11 (Supplementary Fig. 1 online, Supplementary Table S1 online).
Furthermore, R11 has advantages over neutral comet assay in the standardization process of DFI interpretation. Scoring of the comets can be performed with the help of analytic software to reduce inter-observer/technician variability22,23; however, diverse formulae for fragmented DNA calculation exists between laboratories, such as percent DNA in the tail (%), tail length (μm), and tail moment (%)24. This diverse standardization leads to high intra-laboratory variability and no unanimous consensus on a specific cut-off value for clinical reference. Herein, R11 offers a standard binary classification of “halo” for DSBs and “no halo” for intact DNA that minimizes the subjectivity of DFI interpretation. Furthermore, the image-based results have the potential to conjugate with artificial intelligence (AI)-integrated automated system18, thereby making DSB evaluations faster, standardized, and laboratory manageable.
In the present study, we proved R11 sensitivity and specificity using simulated samples (Fig. 3) and also explored the feasibility of the method in biological samples. In a cohort of 640 male patients, R11 showed a significant correlation with total motility, progressive motility, and morphology (Fig. 4), which was in accordance with previous findings6,10,25. However, notwithstanding, sperm DSBs are known to associate with recurrent pregnancy loss; thus, the outcomes of increased DSB were used as a retrospective indicator for patients who have suffered failure(s) of natural conception and/or assisted reproduction attempts14,17. Here, we demonstrated the significant predictive power of R11 in identifying preimplantation embryonic aneuploidy, even in a model that excludes confounding variables related to advanced female age25 (Fig. 5b). Therefore, sperm DSB evaluation can be considered as a primary approach for assessing paternal risk factors and mitigating the impacts associated with DSBs. On the other hand, high probability of embryonic aneuploidy was exclusively identified in the profile of DSBs using R11 but not in total DFI using R10. The findings align with previous studies that compared DSBs profile using neutral comet assay and total DFI using alkaline comet assay14,15,26. It is indicated that the evaluation of total DFI alone may not fully represent the status of sperm chromatin. The combination of these two SDF indexes provides greater sensitivity in understanding the etiology of male factor infertility, which can further assist clinicians in determining treatment strategies. Nevertheless, the limitations of the current study are single-center trial, and small sample size; more clinical trials are needed to solidify the relationship between R11 and ART failures.
In conclusion, we developed a rapid assay for evaluating sperm DSBs, which does not require electrophoresis and has standard criteria for DFI interpretation; these advantages are beneficial to improve the effectiveness of semen analysis in clinical practice. Additionally, R11 is dedicated to early diagnosis of embryonic aneuploidy that can facilitate treatment plan decision-making workflows and reduce the financial and emotional burdens for ART couples.
Data availability
The data used and/or analyzed during the current study available from the corresponding author on reasonable request. The corresponding author has access to all the data and takes responsibility for the integrity of the data and accuracy of the data analysis.
References
de Kretser, D. M. Male infertility. Lancet 349, 787–790. https://doi.org/10.1016/s0140-6736(96)08341-9 (1997).
Choy, J. T. & Eisenberg, M. L. Male infertility as a window to health. Fertil. Steril. 110, 810–814. https://doi.org/10.1016/j.fertnstert.2018.08.015 (2018).
Cooper, T. G. et al. World Health Organization reference values for human semen characteristics. Hum. Reprod. Update 16, 231–245. https://doi.org/10.1093/humupd/dmp048 (2010).
Esteves, S. C. et al. Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations. Andrologia 53, e13874. https://doi.org/10.1111/and.13874 (2021).
Agarwal, A. et al. Sperm DNA fragmentation: A new guideline for clinicians. World J. Mens Health 38, 412–471. https://doi.org/10.5534/wjmh.200128 (2020).
Yan, B. et al. Evaluation of sperm DNA integrity by mean number of sperm DNA breaks rather than sperm DNA fragmentation index. Clin. Chem. 68, 540–549. https://doi.org/10.1093/clinchem/hvab280 (2022).
Guzick, D. S. et al. Sperm morphology, motility, and concentration in fertile and infertile men. N. Engl. J. Med. 345, 1388–1393. https://doi.org/10.1056/NEJMoa003005 (2001).
Lin, H. T. et al. Incorporating sperm DNA fragmentation index with computer-assisted semen morphokinematic parameters as a better window to male fertility. Chin. J. Physiol. 65, 143–150. https://doi.org/10.4103/CJP.CJP_12_22 (2022).
WHO laboratory manual for the examination and processing of human semen. Sixth edn, (Geneva: World Health Organization, 2021).
Chatzimeletiou, K. et al. Evaluation of sperm DNA fragmentation using two different methods: TUNEL via fluorescence microscopy, and flow cytometry. Medicina (Kaunas) 59, 1. https://doi.org/10.3390/medicina59071313 (2023).
Sakkas, D. & Alvarez, J. G. Sperm DNA fragmentation: Mechanisms of origin, impact on reproductive outcome, and analysis. Fertil. Steril. 93, 1027–1036. https://doi.org/10.1016/j.fertnstert.2009.10.046 (2010).
Coban, O., Serdarogullari, M., Yarkiner, Z. & Serakinci, N. Investigating the level of DNA double-strand break in human spermatozoa and its relation to semen characteristics and IVF outcome using phospho-histone H2AX antibody as a biomarker. Andrology 8, 421–426. https://doi.org/10.1111/andr.12689 (2020).
Singh, N. P. & Stephens, R. E. X-ray induced DNA double-strand breaks in human sperm. Mutagenesis 13, 75–79. https://doi.org/10.1093/mutage/13.1.75 (1998).
Ribas-Maynou, J. et al. Double stranded sperm DNA breaks, measured by Comet assay, are associated with unexplained recurrent miscarriage in couples without a female factor. PLoS One 7, e44679. https://doi.org/10.1371/journal.pone.0044679 (2012).
Lara-Cerrillo, S. et al. Sperm selection during ICSI treatments reduces single- but not double-strand DNA break values compared to the semen sample. J. Assist. Reprod. Genet. 38, 1187–1196. https://doi.org/10.1007/s10815-021-02129-w (2021).
Casanovas, A. et al. Double-stranded sperm DNA damage is a cause of delay in embryo development and can impair implantation rates. Fertil. Steril. 111(699–707), e691. https://doi.org/10.1016/j.fertnstert.2018.11.035 (2019).
Ribas-Maynou, J. & Benet, J. Single and double strand sperm DNA damage: Different reproductive effects on male fertility. Genes (Basel) 10, 1. https://doi.org/10.3390/genes10020105 (2019).
Hsu, C. T. et al. Development and integration of LensHooke® R10 for automatic and standardized diagnosis for sperm DNA fragmentation. Andrology https://doi.org/10.1111/andr.13419 (2023).
Cortés-Gutiérrez, E. I. et al. Interpreting sperm DNA damage in a diverse range of mammalian sperm by means of the two-tailed comet assay. Front. Genet. 5, 404. https://doi.org/10.3389/fgene.2014.00404 (2014).
Villani, P. et al. Sperm DNA fragmentation induced by DNAse I and hydrogen peroxide: An in vitro comparative study among different mammalian species. Reproduction 140, 445–452. https://doi.org/10.1530/REP-10-0176 (2010).
Chen, C. H. et al. Blastocyst morphology based on uniform time-point assessments is correlated with mosaic levels in embryos. Front. Genet. 12, 783826. https://doi.org/10.3389/fgene.2021.783826 (2021).
Końca, K. et al. A cross-platform public domain PC image-analysis program for the comet assay. Mutat. Res. 534, 15–20. https://doi.org/10.1016/s1383-5718(02)00251-6 (2003).
González, J. E., Romero, I., Barquinero, J. F. & García, O. Automatic analysis of silver-stained comets by Cell Profiler software. Mutat. Res. 748, 60–64. https://doi.org/10.1016/j.mrgentox.2012.06.007 (2012).
Forchhammer, L. et al. Variation in the measurement of DNA damage by comet assay measured by the ECVAG inter-laboratory validation trial. Mutagenesis 25, 113–123. https://doi.org/10.1093/mutage/gep048 (2010).
Franasiak, J. M. et al. The nature of aneuploidy with increasing age of the female partner: A review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil. Steril. 101, 656–663. https://doi.org/10.1016/j.fertnstert.2013.11.004 (2014).
Ribas-Maynou, J. et al. Alkaline and neutral Comet assay profiles of sperm DNA damage in clinical groups. Hum. Reprod. 27, 652–658. https://doi.org/10.1093/humrep/der461 (2012).
Funding
This study was supported by Bonraybio Co., Ltd., and the Division of Infertility Clinic, Lee Women’s Hospital, Taichung, Taiwan.
Author information
Authors and Affiliations
Contributions
C.T.H., C.I.L., C.C.H., H.C.C., L.S.C., H.M.T., T.A.C., and M.S.L. conceived, designed, and conducted all the experiments; H.C.C. and L.S.C. performed sample collections and conducted all the experiments; L.S.C. and T.E.W. constructed and wrote the manuscript. T.E.W. drafted and revised the article.
Corresponding authors
Ethics declarations
Competing interests
This study was supported by Bonraybio Co., Ltd. C.T. Hsu the owner of Bonraybio Co., Ltd., and T.E. Wang, H.C. Chang, L.S. Chang are employees of Bonraybio Co., Ltd. The employer (C.I. Lee, C.C. Huang, H.M. Tsao, M.S. Lee) of Lee Women’s Hospital has collaborated with Bonraybio Co., Ltd. for IRB approval to obtain human samples to complete this collaborative project. T.A. Chang reports non-financial support from Bonraybio Co., Ltd. Bonraybio Co., Ltd. reports patent applications “Sperm DNA fragmentation kit” granted in Taiwan (patent number: I777336), and published in People’s Republic of China (publication number: CN114660059A), the United State (publication no: US20220195492A1 and US20230075204A1), and Europe (publication no: EP4019646A1).
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, TE., Lee, CI., Huang, CC. et al. Innovative technology for evaluation of sperm DNA double-strand breaks diagnoses male factor infertility and prevents reproductive failures. Sci Rep 13, 18996 (2023). https://doi.org/10.1038/s41598-023-46049-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-46049-4
- Springer Nature Limited